Results 111 to 120 of about 46,383 (210)

Remdesivir as a possible therapeutic option for the COVID-19 [PDF]

, 2020
Al-Homoud, Ali H., Al-Tawfiq, Jaffar A., Memish, Ziad A.   +2 more
core   +1 more source

Access to Medicines: the Role of Intellectual property Law and Policy [PDF]

, 2012
Intellectual property (IP) policy is an important structural determinant of health. Patent policy influences the rate and direction of innovation for health, playing a positive or negative role depending on how it is shaped and implemented.
El Said, Mohammed, Kapczynski, Amy
core  

(The Lancet)red: a missed opportunity. [PDF]

, 2006
Alexandra Calmy, Donnelly, Felipe Garcia de la Vega, Fernando Pascual, Gilks, Marseille, Nathan Ford, Sheila Shettle, Williams   +8 more
core   +2 more sources

Effects of Ritonavir, Lopinavir, and Alcohol on ABC Transporters and Secretion of Bile Acid and Bilirubin in Senescent Hepatocytes. [PDF]

Int J Mol Sci
Chen L, Duran E, Headrick D, Ji C.
europepmc   +1 more source

Zmpste24 deficiency contributes to intervertebral disc degeneration by undermining the stability of the nuclear membrane of nucleus pulposus cells. [PDF]

PeerJ
Han C, Fu S, Wang H, Zhang K, Zhao J.
europepmc   +1 more source

Reassessing the Conduct of Patch Clamp Cardiac Ion Channel Assays to Improve Nonclinical Data Translation to Clinical ECG Changes and Proarrythmia Risk. [PDF]

Clin Transl Sci
Alvarez Baron C, Zhao J, Guo D, Mistry S, De Palma R, Ismaiel OA, Wu WW.   +6 more
europepmc   +1 more source

COVID-19 treatment of hospital patients worldwide at the onset of the pandemic in 2020: a systematic review. [PDF]

BMC Infect Dis
Bosquet A, Affo C, Happe F, Helfer H, Versini E, Mahé I.   +5 more
europepmc   +1 more source

Tolerability of lopinavir versus dolutegravir in children and adolescents with HIV. [PDF]

AIDS
Blankenberger J, Devendra A, Bakaya M, Lee T, Steffy TLF, Makhesi T, Gilbride CJ, Belus JM, Thahane L, Tschumi N, Marake NB, Tarumbiswa T, Huber R, Chammartin F, Labhardt ND, Brown JA.   +15 more
europepmc   +1 more source

Pattern Recognition Algorithms in Pharmacogenomics and Drug Repurposing-Case Study: Ribavirin and Lopinavir. [PDF]

Pharmaceuticals (Basel)
Calvo H, Islas-Díaz D, Hernández-Laureano E.   +2 more
europepmc   +1 more source

Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV. [PDF]

Antimicrob Agents Chemother
Tsirizani L, Waalewijn H, Szubert A, Mulenga V, Chabala C, Bwakura-Dangarembizi M, Chitsamatanga M, Rutebarika DA, Musiime V, Kasozi M, Lugemwa A, McIlleron HM, Burger DM, Gibb DM, Colbers A, Denti P, Wasmann RE, CHAPAS-4 trial team.   +17 more
europepmc   +1 more source